Pulmonology

Researchers noted that a reduction in the frequency of medication regimen has been proven to also aid treatment adherence.

Half of patients admitted to an emergency department for uncontrolled asthma had unknowingly emptied their bronchodilator inhaler, according to a recent study.

The fixed-dose combination therapy from Valeant Pharmaceuticals International is vying to become the first and only approved topical lotion for the condition.

Though patients had a clinically meaningful increase in pre-bronchodilator FEV1, they did not evidence a significantly improved annualized asthma exacerbation rates compared with placebo.

The specifics of the "minor deficiencies" cited by the FDA will be relayed on June 27, 2018, upon the official issuance of the CRL.

The CDC reports that of the 2 million people who get an infection from antibiotic-resistant bacteria each year, about 23,000 die.

Children with autism are nearly twice as likely to have any allergic condition than those without autism, researchers found.

Between 60-80% of pediatric asthma exacerbations are triggered by respiratory pathogens. For most children, the common cold is the culprit.

The rare condition affects 30,000-40,000 US patients annually. Rituximab becomes its first indicated biologic treatment.

A trial of 2 different vitamin D supplementation methods found that one of them is capable of reducing recurrent wheezing in preterm infants.

The fluticasone propionate nasal spray is indicated for treatment of seasonal and perennial allergic rhinitis, as well as the management of sinus pain and pressure associated with pediatric rhinitis.

This week on MDNN: Cinnamon flavoring in e-cigarettes has been found to disrupt the lungs’ anti-bacterial defense system, new hypertension guidelines have increased the condition's prevalence, and the US Congress passed a right-to-try bill.